45
Participants
Start Date
October 24, 2018
Primary Completion Date
May 6, 2021
Study Completion Date
November 29, 2023
Leuprolide Acetate (LA)
Administered intramuscularly as an injection
Nemours Children's Health System /ID# 201331, Jacksonville
Arnold Palmer Hospital /ID# 201624, Orlando
Indiana University /ID# 200526, Indianapolis
Children's Mercy Hospital/ID# 200221, Kansas City
Cook Children's Med. Center /ID# 212937, Fort Worth
Children's Hospital Colorado /ID# 201645, Aurora
Pediatric Endocrine Associates /ID# 201089, Greenwood Village
Rady Children's Hospital San Diego /ID# 202491, San Diego
Multicare Institute for Research and Innovation /ID# 202188, Tacoma
Pediatric Endocrinology Associates /ID# 200629, Long Beach
Van Meter Pediatric Endocrinology /ID# 201688, Atlanta
Rocky Mountain Diabetes and Osteoporosis Center /ID# 209878, Idaho Falls
Pediatric Endocrine Associates /ID# 202396, Boston
University of Minnesota /ID# 200508, Minneapolis
University of Oklahoma /ID# 200659, Tulsa
Penn State Hershey Medical Ctr /ID# 200287, Hershey
Children's Hospital of Philadelphia - Main /ID# 203846, Philadelphia
Pediatric Endocrine Research Associates /ID# 200131, San Juan
Lead Sponsor
AbbVie
INDUSTRY